No Data
No Data
Currently, there is no involvement in smart government-related business for Guoke Hengtai (301370.SZ).
GuoKe HengTai (301370.SZ) expressed on the investor interaction platform on July 5th that our company is a digital supply chain integrated service provider specializing in medical device distribution. We mainly engage in medical device distribution and direct sales business, and provide professional services such as warehousing and logistics distribution, circulation channel management, circulation process information management, and hospital SPD operation management in the process of business development. At present, we have not yet involved in smart government-related businesses.
Guoke Hengtai (301370.SZ): The tax system is now connected to the national tax system, achieving direct communication between the government and enterprises on tax matters.
On July 5th, Gelunhui reported that an investor asked on the investor interaction platform of Guoke Hengtai (301370.SZ), "Does the tax management system in your company's information system help the company and its customers achieve digital tax management? Which partners does it serve?" The company responded that its tax system is connected with the national tax system and has achieved direct linkage between tax and enterprise. It provides services to upstream and downstream partners for automatic invoicing, electronic deduction, tax ticket verification and other scenarios.
Guokehengtai (301370.SZ) plans to jointly establish a joint venture with Danjiangkou Chuangrui to operate the production of medical instruments and provide technology consulting services.
Guoke Hengtai (301370.SZ) announced that the company plans to form a limited partnership with Danjiangkou Chuangrui Enterprise Management Partnership Enterprise...
As of June 7th, 2024, there are 16,674 shareholders in Guoke Hengtai (301370.SZ) company.
On June 17th, Gelonhui reported that according to the shareholder roster regularly issued by China Securities Depository and Clearing Corporation Limited, as of June 7, 2024, the company had a total of 16,674 shareholders.
The pharmaceutical business sector fluctuated and picked up. Yu Shu Min rose 20 cm, Dajia Weikang rose more than 15%, and Pharma Tesco, Chinese Health, Inter Group, Hefu China, and Guoke Hengtai followed suit.
The pharmaceutical business sector fluctuated and picked up. Yu Shu Min rose 20 cm, Dajia Weikang rose more than 15%, and Pharma Tesco, Chinese Health, Inter Group, Hefu China, and Guoke Hengtai followed suit.
Guoke Hengtai (301370.SZ) announced its 2023 annual results. Net profit of 154 million yuan increased 23.19% year over year
Guoke Hengtai (301370.SZ) released the 2023 annual results report. The company achieved operating income during the reporting period...
No Data